| Trial ID: | L5164 |
| Source ID: | NCT01396564
|
| Associated Drug: |
Metformin
|
| Title: |
Pioglitazone and Metformin in Diabetic Children
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Metformin|DRUG: Pioglitazone
|
| Outcome Measures: |
Primary: Short-term comparison of metformin and pioglitazone in pediatric patients with T2D, To compare the effectiveness of metformin vs pioglitazone in children with T2D, in terms of resistin levels and insulin resistance. Compare various markers such as HbA1c,fasting plasma glucose, lipids, and hepatic function., 48 weeks | Secondary: Comparison of long-term effects of metformin vs pioglitazone, To compare the effectiveness of metformin vs pioglitazone in children with T2D, in terms of resistin levels and insulin resistance. Compare various markers such as HbA1c,fasting plasma glucose, lipids, and hepatic function over the long-term, as well as any secondary effects., 10 years
|
| Sponsor/Collaborators: |
Sponsor: Coordinación de Investigación en Salud, Mexico
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
56
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-10
|
| Completion Date: |
2011-07
|
| Results First Posted: |
|
| Last Update Posted: |
2011-07-19
|
| Locations: |
Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN "Siglo XXI", Mexico City, DF, 06720, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01396564
|
